The gut microbiota is an essential component of the human body that has evolved over the time in its hosts. In this symbiotic relationship with the host, the human microbiome operates as an independent organ. Studies suggest that serious health issues arise with this host–microbe interaction disrupted. Alterations in host metabolic outcomes have been associated with modifications to the microbiome’s composition and function. This chapter explores the complex connections between gut health and metabolic syndrome (MetS). Dysbiosis, or gut microbial imbalance, is highlighted as a major contributor to metabolic syndrome. After that, we explore the possibilities of cutting-edge microbiome-based treatments including fecal microbiota transplantation, probiotics, and prebiotics. The chapter also looks at how dietary therapies including Mediterranean, ketogenic, and fiber-rich diets, as well as intermittent fasting, might improve metabolic outcomes. Lastly, we go over to how gut bacteria affect insulin sensitivity, inflammation, and glucose homeostasis in the context of the microbiome’s role in insulin resistance. This thorough review highlights how important gut health is in controlling metabolic syndrome, which may lead to new therapies that target the microbiota.